535.67
United Therapeutics Corp (UTHR) 最新ニュース
United Therapeutics Corp (UTHR) - MSN
United Therapeutics CEO Rothblatt sells $5.04 million in company shares - Investing.com
Form 4 United Therapeutics Corporation For: 17 July By Investing.com - Investing.com Canada
United Therapeutics CEO Rothblatt sells $5.04m in UTHR shares By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.04m in UTHR shares - Investing.com
Form 4 United Therapeutics Corporation For: 16 July By Investing.com - Investing.com Canada
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
Form 4 United Therapeutics Corporation For: 14 July By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.09m in company stock - Investing.com
United Therapeutics CEO Rothblatt sells $5.09m in company stock By Investing.com - Investing.com UK
United Therapeutics (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan
Form 4 United Therapeutics Corporation For: 13 July By Investing.com - Investing.com South Africa
[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan
United Therapeutics director Jan Malcolm sells $178,941 in stock - Investing.com UK
United Therapeutics director Jan Malcolm sells $178,941 in stock By Investing.com - Investing.com Australia
Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus
United Therapeutics: CEO's Multi-Million Dollar Sales Signal Caution Amidst Bullish Consensus - Kavout | AI
Form 4 United Therapeutics Corporation For: 10 July By Investing.com - Investing.com South Africa
UTHR Stock Quote Price and Forecast - CNN
United Therapeutics CEO Martine Rothblatt sells $5.2m shares - Investing.com UK
United Therapeutics CEO Martine Rothblatt sells $5.2m shares By Investing.com - Investing.com Australia
Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.25m By Investing.com - Investing.com Australia
Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.25m - Investing.com
Form 4 United Therapeutics Corporation For: 9 July By Investing.com - Investing.com Canada
United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know - TradingView
United Therapeutics CEO Martine Rothblatt sells $5.3m company stock - Investing.com
Form 4 United Therapeutics Corporation For: 8 July By Investing.com - Investing.com South Africa
United Therapeutics CEO Martine Rothblatt sells $5.3m company stock By Investing.com - Investing.com Nigeria
Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation? - Insider Monkey
United Therapeutics expands immune therapy pipeline with Thymmune - BioBuzz
United Therapeutics focuses on pulmonary arterial hypertension. Nasdaq-listed biotech builds on its - Ad-hoc-news.de
United Therapeutics Corp (UTHR) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 88/100 - GuruFocus
United Therapeutics CEO Rothblatt sells $5.2m in company stock By Investing.com - Investing.com South Africa
Form 4 United Therapeutics Corporation For: 7 July By Investing.com - Investing.com Nigeria
United Therapeutics CEO Rothblatt sells $5.2m in company stock - Investing.com
United Therapeutics: Trifecta Of 2026 Tyvaso Franchise Filings Makes It A Compelling Buy - Seeking Alpha
大文字化:
|
ボリューム (24 時間):